Improving Patient Access to Stroke Therapy Study

Trial Profile

Improving Patient Access to Stroke Therapy Study

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs Alteplase (Primary)
  • Indications Embolism and thrombosis; Stroke; Transient ischaemic attacks
  • Focus Therapeutic Use
  • Acronyms IMPACT
  • Most Recent Events

    • 01 Mar 2017 Status changed from suspended to discontinued.
    • 06 Nov 2015 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 06 Apr 2015 Planned End Date changed from 1 Jul 2014 to 1 Jun 2017 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top